iOnctura announces FDA clearance of IND application for roginolisib, a first-in-class allosteric modulator of PI3Kδ ...Middle East

PR Newswire - News
Roginolisib is in development for solid and hematologic malignancies including uveal melanoma GENEVA and AMSTERDAM, Oct. 31, 2023 /PRNewswire/ -- iOnctura, a clinical-stage biotech developing selective cancer therapies against targets that play critical roles in multiple tumor survival...

Hence then, the article about ionctura announces fda clearance of ind application for roginolisib a first in class allosteric modulator of pi3kd was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( iOnctura announces FDA clearance of IND application for roginolisib, a first-in-class allosteric modulator of PI3Kδ )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News